1 / 33

Correlation of Molecular Subtypes <br />with Survival in AVAglio

Correlation of Molecular Subtypes <br />with Survival in AVAglio. Presented By Heidi Phillips at 2014 ASCO Annual Meeting. Disclosures. Presented By Heidi Phillips at 2014 ASCO Annual Meeting. Introduction. Presented By Heidi Phillips at 2014 ASCO Annual Meeting.

tender
Download Presentation

Correlation of Molecular Subtypes <br />with Survival in AVAglio

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Correlation of Molecular Subtypes <br />with Survival in AVAglio Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  2. Disclosures Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  3. Introduction Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  4. AVAglio Trial Design and Primary Endpoints Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  5. ITT and Biomarker-Evaluable Populations Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  6. ITT and Biomarker-Evaluable Populations Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  7. Methods: Gene Expression Analysis in AVAglio Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  8. Background: Glioblastoma Gene Expression Subtypes Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  9. Results: Gene Expression Subtypes in AVAglio Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  10. Results: OS by Subtype (RT/TMZ + PLB) Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  11. Results: BEV Treatment Impacted PFS in Proneural and Mesenchymal Subtypes Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  12. Results: BEV Effect on OS was Evident Only in the Proneural Subtype Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  13. Results: Effect of BEV on OS was Significant in Univariate and Multivariate Analyses Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  14. Conclusions Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  15. Acknowledgments Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  16. Back-Up Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  17. Biomarker-Evaluable population: clinical covariates Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  18. Baseline Characteristics* of Biomarker-Evaluable Patients and the ITT Population Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  19. Baseline Characteristics* of <br />Proneural and Non-Proneural Subgroups Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  20. Baseline Characteristics* of <br />Proneural and Non-Proneural TCGA Subgroups Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  21. Multivariate Cox PROPORTIONAL HAZARDS Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  22. Multivariate Cox PH for OS <br />(Proneural Tumors) Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  23. Multivariate Cox PH for OS <br />(Non-Proneural Tumors) Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  24. AVAglio Molecular Subtype Classification Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  25. AVAglio Molecular Subtype Classification Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  26. TCGA subtype1 DATA Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  27. PFS by TCGA Subtype and Treatment Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  28. OS by TCGA Subtype and Treatment Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  29. OS Treatment Effect on TCGA Proneural Tumors Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  30. Multivariate Cox PH for OS <br />(TCGA Proneural Tumors) Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  31. Multivariate Cox PH for OS <br />(TCGA Non-Proneural Tumors) Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  32. Nanostring and Affymetrix Correlations Presented By Heidi Phillips at 2014 ASCO Annual Meeting

  33. Nanostring and Affymetrix Correlations Presented By Heidi Phillips at 2014 ASCO Annual Meeting

More Related